王明蛟,李光照,胡彩娜,郭胜存,刘亚东,户富栋,付新,姜正明,陈魁

• 1:郑州大学第一附属医院心内科

摘要(Abstract)：

目的探讨对经导管主动脉瓣置换术(TAVR)后出现高度房室传导阻滞患者植入桥接起搏器的安全性及可行性。方法纳入2019年8月1日至2020年8月1日在郑州大学第一附属医院接受TAVR治疗后出现高度房室传导阻滞而植入桥接起搏器的主动脉瓣重度狭窄患者10例。观察其术后30 d每天心电图变化、血流动力学改善情况及相关并发症发生情况,并评估应用桥接起搏器的安全性和可行性。结果 10例患者术后2 d内均未恢复传导,均给予植入桥接起搏器。所有患者均无起搏器并发症发生。3例患者心脏传导功能分别在TAVR后第8天、第21天、第7天恢复而未植入永久起搏器,其余7例在TAVR后30 d均未恢复心脏传导功能,给予植入永久起搏器。术后1个月随访显示临床症状及心功能改善,超声心动图提示血流动力学改善。结论 TAVR后合并高度房室传导阻滞在术后2 d未恢复心脏传导功能患者植入桥接起搏器是安全及可行的,降低了起搏器植入率且不影响其心功能恢复。

关键词(KeyWords)： 经导管主动脉瓣置换术;传导阻滞;桥接起搏器

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 王明蛟,李光照,胡彩娜,郭胜存,刘亚东,户富栋,付新,姜正明,陈魁

参考文献(References)：

• [1] Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation:results of the Belgian national registry. Interact Cardiovasc Thorac Surg,2011,12(5):762-767.
• [2] Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation:analysis from the German transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv,2013,82(4):E569-E577.
• [3]宋光远，王墨扬，王媛，等. Venus-A主动脉瓣膜介入治疗重度主动脉瓣狭窄的效果.中华心血管病杂志，2017,45(10):843-847.
• [4] Boerlage-Van Dijk K, Kooiman KM, Yong ZY, et al. Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation. Pacing Clin Electrophysiol,2014,37(11):1520-1529.
• [5] Ramazzina C, Knecht S, Jeger R, et al. Pacemaker implantation and need for ventricular pacing during follow-up after transcatheter aortic valve implantation. Pacing Clin Electrophysiol,2014,37(12):1592-1601.
• [6]于海波.经导管主动脉瓣膜置换术后房室传导阻滞的预警.心血管病学进展，2016,37(4):419-422.
• [7] Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv,2008,1(3):310-316.
• [8] Rodés-Cabau J, Ellenbogen KA, Krahn AD, et al. Management of conduction disturbances associated with transcatheter aortic valve replacement:JACC scientifi c expert panel. J Am Coll Cardiol,2019,74(8):1086-1106.
• [9] Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med,2019,380(18):1695-1705.
• [10] Lenders GD, Valérie C, JoséMH, et al. Depth of valve implantation, conduction disturbances and pacemaker implantation with CoreValve and CoreValve Accutrak system for Transcatheter Aortic Valve Implantation, a multi-center study. Int J Cardiol,2014, 176(3):771-775.
• [11] Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J, 2016, 37(28):2252-2262.
• [12] Houthuizen P, Van Garsse LA, Poels TT, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation, 2012, 126(6):720-728.
• [13] Rodés-Cabau J, Ellenbogen KA, Krahn AD, et al. Management of conduction disturbances associated with tyranscatheter aortic valve replacement:JACC scientific expert panel. J Am Coll Cardiol,2019, 74(8):1086-1106.
• [14]郭飞，董建增，王龙，等.感染电极拔除术后主动固定临时起搏与传统临时起搏的对比研究.中国介入心脏病学杂志，2018,26(3):149-153.
• [15] Braun MU, Rauwolf T, Bock M, et al. Percutaneous lead implantation connected to an external device in stimulationdependent patients with systemic infection-a prospective and controlled study. Pacing Clin Electrophysiol, 2006, 29(8):875-879.
• [16] Lever N, Ferguson JD, Bashir Y, et al. Prolonged temporary cardiac pacing using subcutaneous tunnelled active-fixation permanent pacing leads. Heart, 2003, 89(2):209-210.
• [17] Arias MA, Puchol A, Pachón M, et al. Prolonged temporary cardiac pacing using an external permanent pacing system. Rev Esp Cardiol(Engl Ed),2012,65(6):573-574.
• [18] Lepillier A, Otmani A, Waintraub X, et al. Temporary transvenous VDD pacing as a bridge to permanent pacemaker implantation in patients with sepsis and haemodynamically signif icant atrioventricular block. Europace, 2012, 14(7):981-985.